News

June 20, 2023

Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi Syndrome

The FDA granted Aardvark Orphan Drug Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating […]
April 4, 2023

We need more than brain injury awareness: We need new treatment

Advocates push ‘all hands to the pump’ approach in push for more resources By Rep. Bill Pascrell Jr. and Vishal Bansal- March 6, 2023 Rep. […]
November 23, 2022

Why Are We Failing Veterans Who Bravely Served Our Country?

Since 9/11, four times as many US service members have died by suicide as have died in combat. By Frank Larkin and Michael Wyand – […]
October 19, 2022

Exacis Biotherapeutics Grants Eterna Therapeutics an Option to License Up to Four Allogeneic IPSC-Derived NK and T Cell Therapies

Agreement grants Eterna rights to license up to four next-generation iPS cell derived NK and T cell cancer therapies License terms include an upfront license […]